B. Makabipanzu et al., COMPARISON OF CELLULAR ACCUMULATION, TISSUE DISTRIBUTION, AND ANTI-HIV ACTIVITY OF FREE AND LIPOSOMAL 2',3'-DIDEOXYCYTIDINE, AIDS research and human retroviruses, 10(11), 1994, pp. 1463-1470
We have investigated the cellular accumulation, tissue distribution, a
nd antihuman immunodeficiency virus activity of free dideoxycytidine (
ddC) and liposomal ddC (L-ddC). We have found that L-ddC was more effi
ciently taken up than its free form by RAW 264.7 cells (a monocyte-mac
rophage cell line) (p < 0.01) while a comparable uptake was seen in U9
37 cells (a promonocytic cell line). In the rat, L-ddC accumulated pre
ferentially in liver and spleen when injected intravenously (p < 0.01)
, and mostly in spleen when given intraperitoneally (p < 0.01). In con
trast, free ddC was rapidly eliminated out of the body. Liposomal ddC
showed a similar anti-HIV activity in comparison with free ddC in U937
cells. Given the fact that encapsulation of ddC in liposomes does not
affect its anti-HIV activity but enhances its in vitro cellular accum
ulation and its in vivo distribution in reticuloendothelial system (RE
S) tissues, we conclude that ddC in liposomal formulation is a promisi
ng anti-HIV agent with a targeted action on the RES, which is consider
ed a reservoir for dissemination of virus to other cells, tissues, and
organs.